Dose Escalation Study With MK-2206 in Patients With Locally Advanced or Metastatic Solid Tumors (MK-2206-002)

Clinical trial NCT00670488 · COMPLETED

Trial details

NCT number: NCT00670488
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced Tumors Metastatic Solid Tumors Cancer Neoplasms

Start date: 2008-04-15
Primary completion: 2011-07-11
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.